"Administration, Mucosal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Delivery of a drug or other substance into the body through the epithelium lining of MUCOUS MEMBRANE involved with absorption and secretion.
| Descriptor ID |
D058956
|
| MeSH Number(s) |
E02.319.267.120.655
|
| Concept/Terms |
Administration, Mucosal- Administration, Mucosal
- Administrations, Mucosal
- Mucosal Administrations
- Mucosal Administration
- Transmucosal Administration
- Administration, Transmucosal
- Administrations, Transmucosal
- Transmucosal Administrations
Transmucosal Routing- Transmucosal Routing
- Routing, Transmucosal
- Routings, Transmucosal
- Transmucosal Routings
Transmucosal Administration Routes- Transmucosal Administration Routes
- Administration Route, Transmucosal
- Administration Routes, Transmucosal
- Route, Transmucosal Administration
- Routes, Transmucosal Administration
- Transmucosal Administration Route
|
Below are MeSH descriptors whose meaning is more general than "Administration, Mucosal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Mucosal".
This graph shows the total number of publications written about "Administration, Mucosal" by people in this website by year, and whether "Administration, Mucosal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Administration, Mucosal" by people in Profiles.
-
Transmucosal drug administration as an alternative route in palliative and end-of-life care during the COVID-19 pandemic. Adv Drug Deliv Rev. 2020; 160:234-243.
-
Combating COVID-19: MVA Vector Vaccines Applied to the Respiratory Tract as Promising Approach Toward Protective Immunity in the Lung. Front Immunol. 2020; 11:1959.
-
Assessment of the FDA Risk Evaluation and Mitigation Strategy for Transmucosal Immediate-Release Fentanyl Products. JAMA. 2019 Feb 19; 321(7):676-685.
-
Effects of oral and subcutaneous administration of HSP60 on myeloid-derived suppressor cells and atherosclerosis in ApoE-/- mice. Biochem Biophys Res Commun. 2018 04 15; 498(4):701-706.
-
Polymeric penetration enhancers promote humoral immune responses to mucosal vaccines. J Control Release. 2014 Jun 10; 183:43-50.
-
Immune responses to mucosal vaccination by the recombinant A1 and N proteins of infectious bronchitis virus. Viral Immunol. 2012 Feb; 25(1):55-62.